IL6 and COVID-19: It is generally believed that the imbalance in Th1 and Th2 responses in COVID-19 patients triggers a cellular inflammatory storm, and increase the levels of inflammatory mediators such as interleukin IL-4, IL-10, and IL-6 in tissue samples.